Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Complex Phytoadaptogens (CFA)
- Development stage
- Unknown
- Lead developer
- Vladikavkaz Scientific Center of the Russian Academy of Sciences
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Complex Phytoadaptogens (CFA) is a botanical combination therapy developed by the Vladikavkaz Scientific Center of the Russian Academy of Sciences. It consists of 70% alcohol extracts of *Glycyrrhiza glabra* (Licorice), *Rhodiola rosea* (Golden Root), and *Eleutherococcus senticosus* (Siberian Ginseng) in a 2:1:1 ratio. The therapy is investigated as an adjunct to non-surgical periodontal treatment (NSPT) for patients with chronic periodontitis. CFA functions as an adaptogen, enhancing the body's non-specific resistance to stressors and modulating the immune-inflammatory response. A key feature of its clinical application is chronotherapy, where the timing and dosage of the oral drops are adjusted based on the patient's individual chronotype (morning, independent, or evening) to maximize therapeutic efficacy during disease exacerbations.
- Other names
- Cocktail from complex phytoadaptogensCFA chronotherapyPhytoadaptogen cocktail
02
Targets
11-beta-HSD (Corticosteroid 11-beta-dehydrogenase)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on Complex Phytoadaptogens (CFA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Complex Phytoadaptogens (CFA).